Methyl iodide
|
CAS
74-88-4
|
CH3I
|
RTECS
PA9450000
|
Synonyms & Trade Names
Iodomethane, Monoiodomethane
|
DOT ID & Guide
2644 / 151
|
Exposure
Limits
|
NIOSH REL: Ca TWA 2 ppm (10 mg/m3) [skin] See Appendix A
|
|
OSHA PEL: TWA 5 ppm (28 mg/m3) [skin]
|
IDLH
Ca [100 ppm]
See: 74884
|
Conversion
1 ppm = 5.80 mg/m3
|
Physical Description
Colorless liquid with a pungent, ether-like odor. [Note: Turns yellow, red, or brown on exposure to light & moisture.]
|
MW: 141.9
|
BP: 109°F
|
FRZ: -88°F
|
Sol: 1%
|
VP: 400 mmHg
|
IP: 9.54 eV
|
|
Sp.Gr: 2.28
|
Fl.P: NA
|
UEL: NA
|
LEL: NA
|
|
|
Noncombustible Liquid
|
Incompatibilities & Reactivities
Strong oxidizers [Note: Decomposes at 518°F.]
|
Measurement Methods
NIOSH 1014
See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection)
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: When contaminated
Remove: When wet or contaminated
Change: No recommendation
Provide: Eyewash, Quick drench
|
First Aid (See procedures)
Eye: Irrigate immediately
Skin: Soap flush immediately
Breathing: Respiratory support
Swallow: Medical attention immediately
|
Respirator Recommendations
NIOSH
At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration:
(APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode
(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus
Escape:
(APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus
Important additional information about respirator selection
|
Exposure Routes
inhalation, skin absorption, ingestion, skin and/or eye contact
|
Symptoms
Irritation eyes, skin, respiratory system; nausea, vomiting; dizziness, ataxia; slurred speech, drowsiness; dermatitis; [potential occupational carcinogen]
|
Target Organs
Eyes, skin, respiratory system, central nervous system
Cancer Site
[in animals: lung, kidney & forestomach tumors]
|
|
See also: INTRODUCTION See ICSC CARD: 0509
|
